- UroToday Home
- Urologic Oncology
The Latest Bladder Cancer Research
Recent Abstracts
-
The emerging treatment landscape of advanced urothelial carcinoma.Bladder CancerOctober 15, 2021
-
Clinicopathologic analysis of patients undergoing repeat transurethral resection of bladder tumour following an initial diagnosis of urothelial carcinoma with lamina propria invasion and variant/divergent histology.Bladder CancerOctober 15, 2021
-
Role of Blue Light Cystoscopy in Detecting Invasive Bladder Tumor: Data from Multi-Institutional Registry.Bladder CancerOctober 14, 2021
-
Bladder cancer recurrence in papillary urothelial neoplasm of low malignant potential (PUNLMP) compared to G1 WHO 1999: a population-based study.Bladder CancerOctober 14, 2021
-
Clinical indications for necessary and discretionary hospital readmissions after radical cystectomy.Bladder CancerOctober 13, 2021
-
Does neoadjuvant chemotherapy diminish the sex disparity in bladder cancer survival after radical cystectomy?Bladder CancerOctober 13, 2021
-
Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort.Bladder CancerOctober 13, 2021
-
Radical Cystectomy vs. Radiotherapy in Urothelial Bladder Cancer in Elderly and Very Elderly Patients.Bladder CancerOctober 12, 2021
-
Predictive models of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using nuclear morphology and tissue architecture.Bladder CancerOctober 12, 2021
-
A Randomized Feasibility Trial Comparing Surveillance Regimens for Patients with Low and Low-Intermediate Risk Non-Muscle Invasive Bladder Cancer.Bladder CancerOctober 12, 2021
Beyond the Abstracts
-
Society for Immunotherapy of Cancer (SITC) Clinical Practice Guideline on Immunotherapy for the Treatment of Urothelial Cancer - Beyond the AbstractBladder CancerOctober 12, 2021
-
Vaginal Complications after Radical Cystectomy for Bladder Cancer: A Systematic Review - Beyond the AbstractBladder CancerOctober 11, 2021
-
Role of Ki-67, MRE11, and PD-L1 as Predictive Biomarkers for Recurrence Pattern in Muscle-invasive Bladder Cancer - Beyond the AbstractBladder CancerOctober 11, 2021
-
Urologists, You’ll Never Walk Alone! How Novel Immunotherapy and Modern Imaging May Change the Management of Non-Muscle-Invasive Bladder Cancer - Beyond the AbstractBladder CancerOctober 6, 2021
-
Evaluation of Bowel Function Following Radical Cystectomy and Urinary Diversion Using Two Validated Questionnaires: What Are the Effects on Quality of Life? - Beyond the AbstractBladder CancerAugust 17, 2021
-
TERT Promoter Mutations and Other Prognostic Factors in Patients with Advanced Urothelial Carcinoma Treated with an Immune Checkpoint Inhibitor - Beyond the AbstractBladder CancerAugust 13, 2021
-
Early Photodynamic Diagnosis Cystoscopy after BCG Induction for High-Risk Non-Muscle Invasive Bladder Cancer Significantly Increased the Detection of BCG Refractory Tumors - Beyond the AbstractBladder CancerAugust 10, 2021
-
Comparison of Oncologic Outcomes Following Open and Robotic-assisted Radical Cystectomy with both Extracorporeal and Intracorporeal Urinary Diversion - Beyond the AbstractBladder CancerAugust 6, 2021
-
A miRNA Signature Predicts Benefit from Addition of Hypoxia-Modifying Therapy to Radiation Treatment in Invasive Bladder Cancer - Beyond the AbstractBladder CancerJuly 29, 2021
-
Oncological Outcomes of High-Grade T1 Non-Muscle-Invasive Bladder Cancer Treatment in Octogenarians - Beyond the AbstractBladder CancerJuly 26, 2021